E-submission
Get new issue alerts
THE KOREAN LIVER CANCER ASSOCIATION
Search
- Page Path
- HOME > Search
Review Article
- Radiologic features of hepatocellular carcinoma related to prognosis
- Shin Hye Hwang, Hyungjin Rhee
- J Liver Cancer. 2023;23(1):143-156. Published online March 9, 2023
- DOI: https://doi.org/10.17998/jlc.2023.02.16
- 15,733 Views
- 326 Downloads
- 29 Citations
-
Abstract
PDF - The cross-sectional imaging findings play a crucial role in the diagnosis of hepatocellular carcinoma (HCC). Recent studies have shown that imaging findings of HCC are not only relevant for the diagnosis of HCC, but also for identifying genetic and pathologic characteristics and determining prognosis. Imaging findings such as rim arterial phase hyperenhancement, arterial phase peritumoral hyperenhancement, hepatobiliary phase peritumoral hypointensity, non-smooth tumor margin, low apparent diffusion coefficient, and the LR-M category of the Liver Imaging-Reporting and Data System have been reported to be associated with poor prognosis. In contrast, imaging findings such as enhancing capsule appearance, hepatobiliary phase hyperintensity, and fat in mass have been reported to be associated with a favorable prognosis. Most of these imaging findings were examined in retrospective, single-center studies that were not adequately validated. However, the imaging findings can be applied for deciding the treatment strategy for HCC, if their significance can be confirmed by a large multicenter study. In this literature, we would like to review imaging findings related to the prognosis of HCC as well as their associated clinicopathological characteristics.
-
Citations
Citations to this article as recorded by
- Association of Signal Heterogeneity in the Hepatobiliary Phase of Gd‐EOB‐DTPA‐Enhanced MRI With Survival Outcomes and Tumor Microenvironment in Hepatocellular Carcinoma
Munetoshi Akaoka, Koichiro Haruki, Jun Woo, Kazuyoshi Ohki, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Michinori Matsumoto, Yoshihiro Shirai, Toru Ikegami
Journal of Hepato-Biliary-Pancreatic Sciences.2026; 33(5): 352. CrossRef - Focal lesions in the cirrhotic liver: an update on LI-RADS classification and clinical implications
Antonino Andrea Blandino, Federica Vernuccio, Roberto Cannella, Aoife Kilcoyne, Leo L. Tsai, Giuseppe Brancatelli
Digestive and Liver Disease.2026; 58(6): 713. CrossRef - Arterial phase CT improves detection of colorectal liver metastases: evaluation of the downslope injection method
Hiroaki Takayama, Tomoaki Ichikawa, Takayuki Yokota, Yasuhiro Fukushima, Junya Fukuda, Yoshiyuki Sakai, Tomokazu Takeuchi, Koji Muroga, Yoshito Tsushima
European Radiology.2026; 36(7): 5392. CrossRef - Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma
Yong Jun Jung, Seokhwi Kim, In Hye Song, Ju Hyun Shim, Seung Soo Lee, Subin Heo, Sang Hyun Choi
Radiology: Imaging Cancer.2026;[Epub] CrossRef - Imaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advances
Jaeseung Shin, Taek Chung, Sang Yun Ha, Hyungjin Rhee
Journal of Liver Cancer.2026; 26(1): 9. CrossRef - Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Predicting Immunotherapy Response in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Wenbo Xie, Linmao Sun, Yumin Fu, Shuhang Liang, Yao Liu, Jiabei Wang, Lianxin Liu
Liver Cancer.2026; : 1. CrossRef - A modified Rim APHE criterion to improve LI-RADS diagnostic performance for primary liver malignancies
Chunying Feng, Jun Liu, Dawei Yang, Lixue Xu, Min Li, Yan Bao, Jinghui Dong, Jiawen Luo, Qingqing Chen, Rufang Liao, Chenxia Li, Rongpin Wang, Hui Xu, Zhenghan Yang
Abdominal Radiology.2026;[Epub] CrossRef - Habitat and peritumoral CT radiomics accurately predict early treatment response to hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and programmed death−1 inhibitors in unresectable hepatocellular carcinoma
Wenyi Bao, Minghang Shen, Kaidi Long, Bo Huang, Zhiqiang Zhang, Peizhi Li
Frontiers in Oncology.2026;[Epub] CrossRef - Arterial-Phase Enhancement Patterns of Hepatocellular Carcinoma: From Pathologic Background to Prognostication and Treatment Response
Jun Gu Kang, Ja Kyung Yoon, Hyungjin Rhee
Korean Journal of Abdominal Radiology.2026; 9(1): 14. CrossRef - Clinical and LI-RADS features on gadoxetic acid‑enhanced MRI for predicting complete response after transarterial chemoembolization in hepatocellular carcinoma > 2 cm
Chuhang Liu, Shuya Tan, Xinpei Hu, Yaoning Chen, Cen Hu, Hanqi Liu, Tong Zhao, Yujia Chen, Yangyang Liu
Abdominal Radiology.2026;[Epub] CrossRef - Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma
Kyowon Gu, Tae Wook Kang, Jaeseung Shin, Dong Hyun Sinn, Myung Ji Goh, Jung Yong Hong, Sangah Chi, Po-Yao Hsu
PLOS One.2026; 21(7): e0354176. CrossRef - Beyond Diagnosis: Magnetic Resonance Imaging-Based Imaging Biomarkers for Tumor Biology, Prognosis, and Clinical Decision-Making in Hepatocellular Carcinoma
Ja Kyung Yoon, Jin-Young Choi
Korean Journal of Radiology.2026;[Epub] CrossRef - Evolution of Research on Cell-Specific Magnetic Resonance Imaging Contrast Agents in Hepatocellular Carcinoma: A Bibliometric Study
ChenWei Zhang, TianAi Zhang, ShaoZhong Ni
Hepatitis Monthly.2026;[Epub] CrossRef - A Nomogram Based on MRI Visual Decision Tree to Evaluate Vascular Endothelial Growth Factor in Hepatocellular Carcinoma
Hanting Dai, Chuan Yan, Wanrong Huang, Yifan Pan, Feng Pan, Yamei Liu, Shunli Wang, Huifang Wang, Rongping Ye, Yueming Li
Journal of Magnetic Resonance Imaging.2025; 61(2): 970. CrossRef - Prediction early recurrence of hepatocellular carcinoma after hepatectomy using gadoxetic acid-enhanced MRI and IVIM
Da Guo, Liping Liu, Yu Jin
European Journal of Radiology Open.2025; 14: 100643. CrossRef - MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma
Ja Kyung Yoon, Jin-Young Choi
Journal of the Korean Society of Radiology.2025; 86(3): 364. CrossRef - Radiologic and Pathologic Discordance in Hepatocellular Carcinoma: More Than a Mismatch, with Prognostic Significance
Ijin Joo
Gut and Liver.2025; 19(4): 477. CrossRef - Contrast-enhanced MRI for identifying the steatohepatitic hepatocellular carcinoma from small hepatocellular carcinoma
Jiachen Liu, Xiurong Ding, Yanyan Zhang, Hongjun Li
Abdominal Radiology.2025; 51(6): 2831. CrossRef - Proposal of a Mathematical Model for Motion Blur in MRI Images
Tatsuya Kondo, Hiroaki Saito, Tsutomu Kanazawa
Japanese Journal of Radiological Technology.2025; 81(11): n/a. CrossRef - Prognostic prediction of primary liver cancer following transcatheter arterial chemoembolization (TACE) combined with targeted immunotherapy based on CT morphological characteristics
Disi Liu
American Journal of Cancer Research.2025; 15(11): 5014. CrossRef - Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization
Gang Peng, Xiaojing Cao, Xiaoyu Huang, Xiang Zhou
European Journal of Radiology Open.2024; 12: 100551. CrossRef - Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma
Ji Yeon Lee, Pil Soo Sung
Gut and Liver.2024; 18(4): 558. CrossRef - Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment
Hyungjin Rhee, Young Nyun Park, Jin-Young Choi
Korean Journal of Radiology.2024; 25(10): 887. CrossRef - Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis
Dong Hwan Kim, Sang Hyun Choi
Journal of Liver Cancer.2024; 24(2): 192. CrossRef - Gd-EOB-DTPA-enhanced MR imaging features of hepatocellular carcinoma in non-cirrhotic liver
Mingyue Song, Yuhao Tao, Hanjun Zhang, Mingzhan Du, Lingchuan Guo, Chunhong Hu, Weiguo Zhang
Magnetic Resonance Imaging.2024; 114: 110241. CrossRef - Prediction of PD-L1 expression in unresectable hepatocellular carcinoma with gadoxetic acid-enhanced MRI
Jun Gu Kang, Kyunghwa Han, Taek Chung, Hyungjin Rhee
European Journal of Radiology.2024; 181: 111772. CrossRef - The histopathological and molecular heterogeneity of hepatocellular
carcinoma: a narrative review
Wonju Chung, Haeryoung Kim
The Ewha Medical Journal.2024;[Epub] CrossRef - Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma
Eisuke Ueshima, Keitaro Sofue, Takahiro Kodama, Shuhei Yamamoto, Masato Komatsu, Shohei Komatsu, Nobuaki Ishihara, Akihiro Umeno, Takeru Yamaguchi, Masatoshi Hori, Takumi Fukumoto, Tetsuo Takehara, Takamichi Murakami
Liver Cancer.2024; 14(3): 271. CrossRef - Imaging prognostication and tumor biology in hepatocellular carcinoma
Diana Kadi, Marilyn F. Yamamoto, Emily C. Lerner, Hanyu Jiang, Kathryn J. Fowler, Mustafa R. Bashir
Journal of Liver Cancer.2023; 23(2): 284. CrossRef
- Association of Signal Heterogeneity in the Hepatobiliary Phase of Gd‐EOB‐DTPA‐Enhanced MRI With Survival Outcomes and Tumor Microenvironment in Hepatocellular Carcinoma
First
Prev
Follow JLC on Twitter
